text:
Introduction to the study of visual culture, prehistoric to present. Emphasis on form and context, and acquiring understanding of art materials and techniques. This course meets the Core Curriculum requirements for Area II: Fine Arts.
Introduction to Western art from prehistoric cave paintings to Gothic Cathedrals. Focusing on ancient Eurasia, Mesopotamia, Egypt, Greece, Rome, and medieval Europe, this course examines the images, monuments, and ideas that shaped the pre-modern world. This course meets the Core Curriculum requirements for Area II: Fine Arts.
Introduction to Western art from Renaissance painting to current bio-sculpture. Focusing on Europe, its colonies, the United States, and global contemporary art, this course examines the images, monuments, and ideas that shaped the modern world. This course meets the Core Curriculum requirements for Area II: Fine Arts.
ARH 205. African/Native American/Oceanic Art. 3 Hours.
Significant monuments and styles of non-western cultures.
Art and culture of India, China, and Japan. This course meets the Core Curriculum requirements for Area II: Fine Arts.
ARH 405. African Art. 3 Hours.
Survey of the arts of Africa, ranging from Ancient Egypt through the contemporary period.
ARH 409. Egypt in the Age of the Pyramids. 3 Hours.
This course spans the period 5000 B.C through 1550 B.C. (Predynastic and Dynasties 1-17), which encompasses Egypt's pyramid building age. It will focus boradly on the art, archaeology, history, architecture, religion, and literature of this period. It is designed to stand independently of its companion course Imperial and Post-Imperial Egypt.
ARH 410. Imperial and Post Imperial Egypt. 3 Hours.
This course spans the years of 1550 B.C. to the Ptolemaic-Roman periods, which covers Egypt's glorious imperial era (New Kingdom: Dynasties 18-10) and its decline in Dynasties 21-31, with the rise of other empires and Macedonian and Roman control of Egypt. It focuses broadly on the art, archaeology, history, architecture, religion, and literature of this time span and is designed to stand independently of its companion course Egypt in the Age of the Pyramids.
ARH 419. Arts of Death in the Middle Ages. 3 Hours.
The visual culture of death and the afterlife from the Roman catacombs to cadaver tombs, 300-1500.
ARH 421. Italian Renaissance Art. 3 Hours.
The visual arts of the Italian Renaissance (1300-1550) in their historic context.
ARH 422. The Birth of Painting: Portable Pictures Across Renaissance Europe. 3 Hours.
The emergence of modern easel painting, 1300-1600.
ARH 423. Study Abroad: European Art. 3 Hours.
On-site study of art and architecture in Europe.
ARH 424. Northern Renasissance Art. 3 Hours.
The visual arts of the Northern Renaissance (1300-1600) in their historic context.
ARH 430. Eighteenth-Century Art in Europe. 3 Hours.
Visual culture in eighteenth-century Britain and France, including study of eighteenth-century holdings in the Birmingham Museum of Art.
ARH 431. Seventeenth-Century Painting. 3 Hours.
Painting in Europe from Italian and Spanish Baroque through the Dutch Golden Age.
ARH 435. Arts of Power in Early Modern Europe. 3 Hours.
The visual arts in service of kings, popes, and the people, 1300-1700.
ARH 440. 19th-Century Art I: Neoclassicism, Romanticism, Realism. 3 Hours.
Painting, sculpture, and graphic arts in Europe, 1780-1860.
ARH 441. 19th-Century Art II: Impressionism and Post-Impressionism. 3 Hours.
Painting. sculpture, and graphic arts in Europe, 1860-1900.
ARH 450. American Art to 1900. 3 Hours.
Painting, sculpture, and architecture in the U.S., with an emphasis on 19th Century.
ARH 460. Twentieth-Century Art to 1945. 3 Hours.
Painting, sculpture, and architecture in Europe and the United States, 1900-1945.
ARH 461. Modern Design. 3 Hours.
History of modern design. Will examine various design disciplines, design theory, well as the relationships betwen design, fine art, architecture and popular culture.
ARH 464. Art Since 1945. 3 Hours.
Painting, sculpture, and architecture primarily in the United States, 1945 to present.
ARH 465. Aspects of Contemporary Art. 3 Hours.
Topics in contemporary art, ca. 1970 to the present. Course offerings will vary from year to year and will study a specific historical moment, medium, theme, or subject.
ARH 467. Modern Architecture. 3 Hours.
History of modern architecture, covering examples from the late 18th century to the present and emphasizing the United States.
ARH 468. Race and Representation. 3 Hours.
History of 20th-Century African American art in context of contemporary theories of identity and issues of diversity, and in relation to African art. Includes study of objects in the Birmingham Museum of Art. Ethics and Civic Responsibility are significant components of this course.
ARH 470. Tomb Art in East Asia. 3 Hours.
What is the purpose of a tomb? How do its structure and décor convey ancient perceptions of death? Who are the occupants, and how did they envision their journey into the afterlife? This course is a survey of the funerary arts of China, Korea, and Japan. By investigating tombs, shrines, sarcophagi, wall paintings, and grave goods throughout East Asia, we will gain a deeper understanding of ancient religions, social structures, ethnic identities, and cross-cultural interactions. Lectures will be supplemented by several visits to the Museum's Asian collections.
ARH 471. Topics in Asian Cinema. 3 Hours.
This course offers students an introduction to a vital aspect of contemporary Asian culture, recognizing that film can be an important focus of contemporary, cultural commentary and critique. The course presumes no prior knowledge of Asia or cinema and its artistic tradition. The goal of the course is to view and discuss, as a class, approximately ten films, emphasizing an understanding of their cultural background and an appreciation of their aesthetic merits as films and cultural settings in Asia. Attendance at weekly screenings is mandatory. Ethics and Civic Responsibility are significant components of this course.
ARH 472. Buddhist & Hindu Art in India to 1200. 3 Hours.
This course explores the environments of worship and devotion particular to India’s major indigenous religious traditions, from their earliest expressions in approximately the fifth century BCE through to the arrival of Islam in India, ca. 1200. We will examine aesthetic conventions, religious ideals, and urban cultures by focusing on the sculpture and architecture traditions of Hinduism, Buddhism, and Jainism.
ARH 473. Japanese Prints/Printmakers. 3 Hours.
A history of Japanese block prints and printmakers from seventeenth through twentieth centuries.
ARH 474. Landscape and Image in East Asia. 3 Hours.
This course surveys the major traditions of landscape art in East Asia. We will explore the ways in which places and spaces are transformed into famous places and sacred sites and consider the critical role played by visual representation in this process. Major topics include the relationship between landscape and power,cultural memory, literature, mythology, seasonality, travel, and literati culture. We will examine the functions of landscape art in various cultural, geographical, and temporal contexts of East Asia. We will look at landscape painting in China from the Tang through the Ming dynasties and consider the complex processes of cultural dissemination and adaptation by looking at the reception of Chinese landscape painting tradition in Korea and Japan.
ARH 475. Japanese Art. 3 Hours.
Art and culture, Neolithic era through nineteenth century.
ARH 477. Piety and Power: Art in India after 1200. 3 Hours.
This course looks at the arts of India after 1200, when Indian art and culture was increasingly influenced and altered by religious and secular powers from outside the subcontinent. We will examine Islamic art and architecture under the patronage of various Sultanate traditions, and finally the Mughals, who expressed their power and piety in monumental architecture and extensively illustrated books. We will also consider the influence of Europeans in South Asia, culminating with the colonial project of the British Raj. Ongoing negotiations between these newly-arriving groups and Indians older, indigenous traditions will be studied. Throughout the course we will dissect the categories of knowledge about South Asia and its art that were constructed primarily by the British, considering, for example, the usefulness of dividing India’s art history into categories of “Hindu,” “Islamic,” “European,” and etc.
ARH 478. Buddhist Arts of East Asia. 3 Hours.
Survey of art and architecture created for Buddhist religious purposes in China, Japan, and to a lesser extent Korea and Central Asia. The course will include a brief overview of Buddhist monuments in South Asia, study of the iconography of Buddhist images in graphic and sculptural media, and analysis of a variety of Buddhist styles in painting, sculpture, and architecture.
ARH 479. Study Abroad: Art & Culture of South Asia. 3 Hours.
This course allows students to become immersed in the art and culture of Asia through direct experience in the field. Focus will primarily be on South Asia but may vary with each course offering to include Nepal, Tibet, and Southeast Asia. Preliminary lectures in Birmingham and significant written assignments required.
ARH 480. Art Criticism and Theory. 3 Hours.
A topics course on subjects in art criticism and theory. The specific focus will vary by instructor and may emphasize either non-Western or Western theories, criticisms, and approaches.
ARH 481. Special Topics: Early Modern Art. 3 Hours.
Special topics in the arts of the Early Modern period in the Western art tradition. Subject will vary with each offering.
ARH 482. Special Topics: Modern Art. 3 Hours.
A special topics course on subjects in the Modern period in the Western tradition, beginning in the later eighteen century. Specific course topics will vary by semester.
ARH 483. Special Topics: Gender and the Visual Arts. 3 Hours.
Topic will vary, depending on instructor. This course will address ways in which gender has affected the history of artistic practice and patronage. It will consider such issues as the gendering of pictorial practice and space, strategies of representing gendered subjects, and the impact of women as patrons of art and architecture.
ARH 484. Special Topics: Contemporary Art. 3 Hours.
Special topics in the arts of the Contemporary period in the Western Art tradition. Subject will vary with each offering.
ARH 485. Special Topics: Museum Studies. 3 Hours.
Museum operation; organization and preparation of exhibitions; cataloging objects in collection; experience with UAB Institute of Visual Art and Birmingham Museum of Art.
ARH 486. Special Topics: South Asia. 3 Hours.
Special topics in the arts of South Asia. Subject will vary with each offering.
ARH 487. Special Topics: Field Study. 3 Hours.
Trips to prominent museums and galleries in United States. Preliminary lectures in Birmingham and significant written assignments required.
ARH 488. Special Topics: East Asian Art. 3 Hours.
Special topics in the arts of East Asia. Subject will vary with each offering.
ARH 489. Art History Senior Capstone. 3 Hours.
This course will assess students’ knowledge of art history and assist them in applying what they have learned. Students will explore post-baccalaureate options, prepare professional materials, and hone art historical skills through a variety of activities such as conducting research, writing for different audiences, curating exhibitions, and presenting research at a symposium. Offered each fall. Should be taken at the senior level.
ARH 490. Art Theory: Special Topics. 3 Hours.
Topic of art theory will vary with each offering.
ARH 491. Independent Study. 3-4 Hours.
Project proposed by student and approved by Art History instructor.
ARH 492. Museum/Gallery Internship. 3 Hours.
Through active participation in the daily operations of a museum, gallery, or art space, students will acquire direct working knowledge of a cooperating art institution. Students will be required to work at the institution a minimum of 10 supervised hours per week during the term.
ARH 493. Seminar: South Asian Art. 3 Hours.
Seminar in the arts of South Asia. Subject will vary with each offering.
ARH 494. Seminar: East Asian Art. 3 Hours.
Seminar in the arts of East Asia. Subject will vary with each offering.
ARH 495. Seminar: Early Modern Art. 3 Hours.
Seminar in Early Modern Art. Subject will vary with each offering.
ARH 496. Seminar: Modern Art. 3 Hours.
Seminar in Modern Art. Subject will vary with each offering.
ARH 497. Seminar: Contemporary Art. 3 Hours.
Seminar in Contemporary Art. Subject will vary with each offering.
ARH 498. AEIVA Internship. 3 Hours.
ARH 499. Honors Thesis. 3 Hours.
For students accepted into honors program in art history. Directed study in art history, in which student works with a faculty mentor to write an extensive research paper on a topic of the student's choice. Recommended to be taken at the senior level, the semester prior to graduation.Permission of instructor required. ARH 489 recommended.

matches:
Art. 3
Art. 3
Art. 3
Art. 3
Art. 3
Art. 3
Art. 3
Art. 3
Art. 3
Art. 3
Art. 3
Art. 3
Art. 3
Art. 3
Art. 3
Art. 3


text:
The Supreme Court of the United States of America is the highest court system in the nation. The Supreme Court, as a result of this classification and function, possesses ultimate, however largely discretionary, appellate jurisdiction over all State and Federal court systems, as well as original jurisdiction over local courts, in the United States.
The Supreme Court of the United States meets in Washington, D.C. in the United States Supreme Court Building. The Supreme Court consists of a Chief Justice and eight acting Associate Justices who are nominated by the President of the United States of America and subsequently confirmed by the U.S. Senate. When a Chief Justice is appointed, he or she maintains life tenure unless they are removed after impeachment.
What are Supreme Court Judgments?
Supreme Court judgments are regarded as the most influential and all-encompassing verdicts or rulings in the nation. The vast majority of Supreme Court judgments either ratifies a Constitutional provision or at least evaluates the intricacies revolving around a particular case in alignment with the United States Constitution or State Constitutions. In addition, all Supreme Court judgments are forms of appeals. All cases heard before a Supreme Court are previously-rendered decisions of a lower court system in the United States.
What is the Supreme Court Cases List?
The Supreme Court Cases List refers to the tangible archives, which store and house all Supreme Court judgments. In addition to the Supreme Court judgments or precedents established through the Supreme Court judgments, the Case List will outline the main points of the legal matter, as well as the intricacies aligned with the case. The Supreme Court Case List will also include all testimonials, significant entries of evidence, as well as crucial dialogue that was latent in the particular Supreme Court judgments.
Marbury v. Madison (1803): This particular Supreme Court judgment is regarded as the keystone power of Judicial Review.
Through this Supreme Court judgment, Judicial Review (the premise that a court system may oversee and nullify actions of another branch of Government) was affirmed and formally established in this case. Marbury v. Madison is viewed as a historical and fundamental court decision that effectively altered the way a judicial body reviewed a case in alignment with a country’s Constitution. This landmark Supreme Court case was the first in the history of any judicial system to deem a ruling unconstitutional.
Dred Scott v. Sanford (1857): This Supreme Court judgment classified slaves as personal property. Although this ruling would be modified with subsequent legislation, this particular landmark Supreme Court case essentially fueled the flames that led to the Civil War.
Brown v. Board of Education of Topeka (1954): A landmark Supreme Court judgment that acted as a groundbreaking step towards civil rights and the delivery of equal rights for all citizens of the United States. Brown v. Board of Education effectively ended the segregation of public schools throughout the United States of America.
NAACP v. Alabama (1958): A landmark Supreme Court judgment which protected the freedom of association. This ruling enabled citizens of the United States to assemble in groups for a common political or human rights-based objective.
Wesberry v. Sanders (1964): The landmark Supreme Court judgment declared each person’s vote to carry an equal measure.
Roe v. Wade (1973): A highly controversial Supreme Court judgment, which rules that states can and cannot control legality issues in regards to abortions.
United States v. Nixon (1974): A landmark Supreme Court judgment that limited the President’s “Executive Privilege”, which in essence, limited the Commander-in-Chief’s authority and ability to exercise particular powers.

matches: v. v. v. v. v. v. v. v. v.


text:
1. Was Margaret Holand, daughter of Sir Robert Holand and Maud la Zouche, the wife of Sir John Tempest (1283-1356)?
2. Who was the wife of Sir John Tempest (b. ca 1313)?
3. Who were the parents of Mary Talbot, the wife of Richard Tempest (d. ca 1390)?
4. Who was the wife of Sir Richard Tempest (1356-1428)?
5. Who were the parents of Isabel Tempest who married Laurence Hamerton?
We take as our point of departure a manuscript written by Eleanor Blanche Tempest in the 1910s and early 20s. The manuscript, Tempest Pedigrees, is in the British Library (Add. MS 40,670) and a copy exists at Broughton Hall, near Skipton. We have examined the British Library copy but not the manuscript at Broughton, so we do not know whether there are differences in these documents. The British Library manuscript is a large folio document of 22 sheets, in which the text area of each sheet is about 24 by 20 inches. It is written in small black script, with citations in red ink and various coats of arms scattered about, in color. The sheets are crammed with information about the early Tempests, with meticulous documentation. The earliest Tempest recorded on these sheets is Roger, who lived in the early 12th Century and was an associate of the Rumellis, who established the monastery of Embsay, the predecessor of Bolton Abbey. We have made use of only a few of the sheets in our explorations, those having to do with the ancestors of Isabel Tempest who married Laurence Hamerton. Isabel and Laurence were ancestors of Peter Worden, the immigrant to Massachusetts. Some individuals appear two or more times on these sheets, sometimes with differing information. In the following, "EBT" refers either to the author or to her manuscript. EBT appears to be the source for a number of Burke's pedigrees of the Tempests, including those in Landed Gentry, Family Records, and Peerage and Baronetage. However, none of those pedigrees matches the EBT manuscript exactly. An article by R. W. Hoyle, "The Fortunes of the Tempest Family of Bracewell and Bowling in the Sixteenth Century" (Yorkshire Archaeological Journal, v. 74, 2002, pp. 169-189) is based largely on Mrs. Tempest’s work.
Eleanor Blanche Tempest was born in 1853, the daughter of Edward Reynard of Sunderlandwick, East Riding Yorkshire. She married Arthur Cecil Tempest who held the Tempest estate at Broughton as a direct male descendant of the earliest Tempests. She died in 1928. She was clearly a remarkable woman. Blind in one eye, she undertook extensive genealogical studies of her husband's heritage and of other families of Yorkshire. Ms. Tempest acquired a large library of genealogical books at Broughton Hall, as well as manuscripts and other documents. It is evident that she spent many hours at the British Museum, the Bodleian Library at Oxford, the Public Record Office, and public and private repositories in Yorkshire and Lancashire. In addition, she was evidently in close contact with other antiquaries of the day and other collectors of ancient documents. She was a member of the Historical Society of Lancashire and Cheshire and wrote a number of articles in its Proceedings as well as in the Genealogist, the Yorkshire Archaeological Society journals, and the Bradford Antiquary. She was also a wood carver, responsible for a number of mantel pieces in Broughton Hall.
Bracewell, the original manor of the Tempests, has not been in the family since the mid-seventeenth century. However, Broughton Hall, not far away and just off the A59 highway, continues in the Tempest family to this day. Henry Roger Tempest, EBT's grandson, lives there. He has given over control of the estate to his son Roger Henry Tempest. In 1987, Henry Roger commissioned and privately printed a book by M. E. Lancaster, The Tempests of Broughton (the front matter indicates it is available from The Estate Office, Broughton Hall, Broughton, Skipton, N. Yorkshire, BD23 3AE). This book is based largely on EBT, with additional material on the Tempests since 1920. Lancaster may also have had access to the archives in Broughton Hall. The book gives some sources, apparently mostly copied from EBT (occasionally in error), but much of it is undocumented. It is a useful resource, but not a substitute for EBT's manuscript. In preparing this note, in addition to EBT, we have consulted original sources (manuscripts in the British Library, the National Archives, and elsewhere), "quasi-original" sources (that is, transcripts, translations, and calendars of original documents), and secondary sources (these include sources such as the Dodsworth manuscripts in the Bodleian Library and Harleian MSS in the BL as well as various published sources from the 18th Century onwards). We have attempted to verify critical citations in EBT, although a few continue to elude us.
We believe that the male line shown here is correct, the concern here is with the last five women.
WAS MARGARET HOLAND, DAUGHTER OF SIR ROBERT HOLAND AND MAUD LA ZOUCHE, THE WIFE OF SIR JOHN TEMPEST?
Sir John Tempest of Bracewell, Broughton, etc. was born 24 Aug. 1283 (proof of age is found in the Calendar of Inquisitions Post Mortem, hereafter CIPM, v. 4, p. 171, see also Yorkshire Inquisitions III, Yorkshire Archaeological Society Record Series, hereafter YASRS, v. 37, p. 92-93). The last evidence of Sir John Tempest was 25 June 1356 when he witnessed a grant in Elslack (next to Broughton). EBT believes he died soon after. EBT and a number of Burke’s publications show Sir John’s wife as Margaret, daughter of Sir Robert Holand by his wife Maud, daughter of Alan lord Zouche. As support for this attribution, EBT quotes a manuscript by Roger Dodsworth (Dodsw. 6, fol. 54, in the Bodleian Library, this should be f. 53, f. 54 is a continuation of the Tempest pedigree that is not relevant here). The Dodsworth MS is the source for a pedigree in Harleian 6136, p. 18 in the British Library, also Harleian 4630, f. 388. EBT also quotes the Visitation of Devon 1562 (Harleian 5185, and the printed version of this, the Visitation of the County of Devon 1564 with additions from the earlier Visitation of 1551, ed. by Frederick Thomas Colby, 1881, Exeter, privately printed, online). However, EBT appears to have misread the Dodsworth MS, which shows Margaret Holand as the wife of Sir John Tempest’s son, John (see below). The Visitation of Devon has a pedigree of the Holand family which shows Margaret Holand as married to John Tempest, but does not specify father or son.
The above Margaret, daughter of Sir Robert Holand, is shown in a number of sources to have been the wife of John la Warre, who died shortly before 24 June 1331, having married before 1326 (Complete Peerage, hereafter CP, v. 4, p. 144, quoting Fine Roll, 5 Edw. III, 1331-32, m. 13, this is in Calendar of Fine Rolls, v. 4, 1327-37, p. 264, see also Ibid. p. 505). The widow of John la Warre died in 1349, according to her IPM (CIPM v. 9, p. 239-40).
We believe that it is unlikely that Sir John Tempest’s wife was Margaret, daughter of Sir Robert Holand. According to CP (v. 6, p. 530) Sir Robert Holand did not marry Maud la Zouche until about 1311 and certainly no later than 1314 (citing CIPM, v. 5, p. 255). Hence, they could not be grandparents of the second John Tempest.
There is also the matter of a Papal Indult in June 1344 to John Tempest, Knight, and Isabel his wife to select their confessors at the hour of their deaths (Calendar of Papal Registers, Papal Letters, v. 3, p. 179, we have confirmed this entry in CPR through examination of an image of the original of this indult from the Vatican Secret Archives, Registri Vaticani 166, f. 347v, number 165). EBT says "Either Sir John had a first wife 'Isabel' or the Holand wife was so called. The son John Tempest was not a knight by 1344 [hence, the CPR reference could not have been to him]."
The marriage of Sir Robert de Holand and Maud la Zouche and Maud's birth in about 1290 are well established by the inquests at the death of her father, Alan la Zouche (CIPM, v. 5, pp. 255-259, the first dated 27 March 7 Edw. II ) in which Maud is identified as wife of Sir Robert de Holand and as age 24 (she had an elder sister, Ellen, wife of Sir Nicholas de Sancto Mauro, age 26, and a younger sister Elizabeth, age 20, a nun; Ellen and Maud are identified as coheirs). It is not clear why CP says Robert and Maud were married “about 1311” (when she would have been 21) but it was certainly before March 1314 (when she was 24). Of course, they could have been married earlier, say as early as 1305.
CP (v. 6, p. 528) says Sir Robert Holand was probably born about 1270, apparently basing that on the fact that his father settled upon him a tenement in 1292 (William Farrer, Lancashire Final Concords I, Record Society of Lancashire and Cheshire, v. 39, p. 173), that he was in the favor of the Earl of Lancaster in 1300 (Calendar of Close Rolls, 1296-1302, p. 365), and that he was a commissioner in 1303 (Calendar of Patent Rolls, 1301-03, p. 191, see also Calendar of Charter Rolls, vol. 3, pp. 43, 45, 79, 289). Douglas Richardson (Plantagenet Ancestry, 2004, p. 398) says he was born about 1283, basing that on an article by J. R. Maddicott in The English Historical Review, v. 86, p. 452, note. Maddicott bases this birthdate on the fact that Robert was not a knight in May 1302 (Coucher Book of Whalley Abbey, 4: 980-81) but was a knight in Sept. 1305 (Hatton’s Book of Seals, no. 223). So Maddicott imagines that he was knighted c. 1304 “at the usual age of 21.” Furthermore Holand was a vallettus to Thomas of Lancaster in 1298 which suggests to Maddicott that he was underage at that time. Obviously, knighthood could be conferred at a later age. The birthdate of 1283 seems a little late to us but it is possible that the truth is somewhere between the estimates of CP and Maddicott. If Robert was born in 1270, he would have been 20 years older than his wife, giving him time to have had a previous wife.
Sir Robert Holand was beheaded 7 Oct. 1328 (Calendar of Inquisitions Miscellaneous, v. 2, p. 270 and other sources) by adherents of Thomas, Earl of Lancaster, for his alleged betrayal of Thomas at the battle of Boroughbridge in 1322. Maud died 31 May 1349 (CIPM, v. 9, p. 178; Lancashire Inquests & Extents, III, Record Society of Lancashire and Cheshire, v. 70, 1913-14, p. 201). Richardson says they had 4 sons and 5 daughters, Isabel, Margaret, Maud, Elizabeth, and Eleanor. Cal. Pat. Rolls 1321-24, p. 75, records an order of 26 February 1322 to conduct a daughter (unnamed) of Robert Holand to the Tower of London along with Aline and John, the wife and son of John de Mowbray. As noted above, CP says Margaret Holand's parents, Robert and Maud (la Zouche) were married about 1311, certainly before 1314, but as noted above, the date could have been (though unlikely) as early as 1305. Hence, Margaret could have been born as early as 1306 or as late as 1314, assuming she was a first child, a big assumption. In any event, she would not have been married (to John Tempest or John la Warre) before 1321 and could not have given birth to John Tempest, born about 1312.
For the record, we note that Sir Robert de Holand and Maud la Zouche had a daughter, Isabel, the second wife of John de Warenne, eighth earl of Surrey (CPR, Edward III 1345-48, 12 December 1346, p. 221). This Isabel could not have been John Tempest’s wife, since, as noted above, no daughter of Robert and Maud could have been his wife.
The above analysis depends considerably on the presumed date of birth of the second John Tempest. EBT shows this in different places in her manuscript as 1308 or 1313. Could John have been born later, such that he could have been the grandson of Sir Robert Holand and Maud la Zouche? The only birthdates in this part of the Tempest line that we know with relative confidence are those of John's father (the senior John Tempest), 1283 by evidence of the proof of age, and this John's great-grandson, Richard (whom we discuss later), born 1356, according to his testimony in the Scrope vs. Grosvenor proceeding. Counting back from that date, it is hard to imagine that Richard's grandfather, the second John, could have been born after 1320, at the latest. This is still too early for John to have been the grandson of Sir Robert Holand and Maud la Zouche, even if they were married in 1305, which is unlikely. We believe the outside limits for the second John Tempest's birth are 1303 to 1313, most probably between 1305 and 1311.
We believe that Sir John Tempest's wife was not Margaret, daughter of Robert de Holand and Maud la Zouche, nor any other daughter of Robert and Maud (e.g., Katherine or Isabel). She may have been a Margaret (although the Papal Indult indicates that John's wife in 1344 was an Isabel). A daughter of Robert de Holand and Elizabeth de Samlesbury would fit better on chronological grounds. If so, it was probably not Margaret, since Robert and Elizabeth's daughter Margaret is known to have been married to John Blackburn, Robert de Hephale, and Adam Banester. And accounts of Robert and Elizabeth's family do not include daughters named Isabel, Katherine, or Mary. We conclude that we do not know the identity of Sir John Tempest's wife.
We should note that if John Tempest married a daughter of Robert de Holand and Elizabeth de Samlesbury, his son John Tempest (see next) and his wife Katherine Sherburne would be related in the second and third degree, clearly prohibited. We do not find in the Calendar of Papal Registers permission for this marriage. Other high officials of the church could issue dispensations and we have examined the published registers of William Melton, Archbishop of York during this period (Canterbury and York Society, vols. 70, 71, 76, 85, 93) also without finding relevant records. However, not all of Melton's registers have been published (they appear to be kept at the Borthwick Institute at the University of York). Some dispensations and licenses for marriage by the Archbishops of York, Bishops of Durham, and Archdeacons of Richmond from 1308-1531 are found in Testamenta Eboracensia volumes 3 and 4 (volumes 45 and 53 of the Surtees Society Publications). We do not find a dispensation for John and Katherine in this source. Of course, failure to find a dispensation is not definitive evidence that John did not marry a Holand.
A possible clue to the first John's wife may lie in transactions relating to rights to his marriage. His father, Richard, died 29 Sept. 1297, before John came of age (he was 14) and Richard's lands and the rights to his marriage were taken into the king' hands. The king apparently granted John's marriage to Bolton priory which then sold it to William Mauleverer in 1299-1300 (Bolton Priory Compotus 1287-1325, v. 154 of Yorks. Arch. Soc., 2000, pp. 101, 115). The Tempests were associated both before and after John with Mauleverers, that is, their names appear as witnesses together to various transactions. On the possibility that Mauleverer had in mind marrying John to his daughter, we have attempted to find a William Mauleverer of the right age with a daughter, perhaps even a daughter named Isabel. So far, we have been unsuccessful in this search.

matches: v. v. v. v. v. v. v. v. v. v. v. v. v. v. v.


text:
French C.J.; Gummow, Hayne, Heydon & Kiefel, JJ.
Panayotides & Panayotides (1997) FLC 92-733, M.W. v. Director-General, Department of Community Services  HCA 12, Zafiropoulos and State Central Authority (2006) FLC 93-264, State Central Authority and De Blasio  FamCA 804, S.K. v. K.P.  3 NZLR 590, Punter v. Secretary for Justice  1 NZLR 40, Mozes v. Mozes (2001) 239 F.3d 1067, Re J. (a Minor) (Abduction: Custody Rights)  2 AC 562, Cooper & Casey (1995) FLC 92-575, D.W. v. Director-General, Department of Child Safety (2006) FLC 93-255, M. & M. (Abduction: England and Scotland)  2 FLR 263, Cameron & Cameron  SC 17, Dixon v Dixon 1990 SCLR 692, D.P. & Commonwealth Central Authority; JLM v Director-General NSW Department of Community Services (2001) 206 CLR 401, De L. & Director General, NSW Department of Community Services and Anor (1996) 187 CLR 640.
The application related to four boys who were aged 10, 7, 5 and 3 years at the time of the appellate hearing. Until May 2006 they had spent their entire lives in Israel with their married parents. The mother was Australian and she had relocated to Israel for the purposes of her marriage.
In 2005 the parents' marriage encountered difficulties and in September 2005 the father moved out of the family home. On 16 May 2006 the mother and children left Israel to travel to Australia. The father took them to the airport and a return to Israel was booked for 27 August 2006. The children commenced school in Sydney on 30 May 2006.
There was disagreement between the parents as to the terms and conditions under which the mother left Israel with the children. The mother asserted she left on an understanding that if the father advised her that the marriage was over, she would not be returning and would settle permanently with the children in Australia. The father asserted that the mother had left for a fixed period only and that he never consented to the children remaining away from Israel on any permanent basis.
The mother duly did not return with the children on 27 August 2006. The father then attempted to secure a return by agreement and when that was not successful he subsequently invoked his rights under the Convention. On 29 August 2007 the Family Court of Australia ordered the return of the children, subject to undertakings:  FAMCA 1099.
The Full Court of the Family Court of Australia dismissed the mother's appeal and ordered the return of the children; the retention was wrongful for the children had neither lost their Israeli habitual residence at the relevant date nor acquired a habitual residence in Australia.
There was, moreover, no grave risk of harm and whilst the father had at one stage consented to the relocation the trial judge had correctly exercised his discretion to make a return order. The mother appealed to the High Court.
Appeal allowed and application dismissed; the retention was not wrongful as the children had lost their Israeli habitual residence by the relevant date.
The High Court noted that in the first appeal: Kilah v. Director-General, Department of Community Services  FamCAFC 81 [INCADAT Reference: HC/E/AU 995], the Full Court of the Family Court of Australia had held that the "settled intention" or "settled purpose" of the mother was a necessary and integral part of determining the children's habitual residence.
The High Court ruled that the Full Court had erred in treating the absence of a settled purpose of abandoning the Israeli habitual residence as being the determining factor.
In reaching this position the High Court reviewed the evolution of habitual residence, as well as case law and doctrine surrounding the connecting factor. The High Court accepted that there were limitations in simply approaching the term as a question of fact. It held that the criteria to be engaged in giving the term meaning were to be found in the "ordinary meaning of the composite term". It would be wrong to devise further definition.
The High Court conceded that, although unlikely, there could be situations where a person had more than one habitual residence. It was clear however, that a person could have no habitual residence at a given moment in time, having abandoned one without having acquired a replacement.
In considering a child's habitual residence regard had to be paid to the context in which the inquiry was being made. In this, the Hague Convention was seeking to facilitate the resolution of disputes between parents relating to a child's care, welfare and development in one forum (the place of habitual residence) rather than any other.
It would usually be very important to examine where the person or persons who were caring for the child had their habitual residence. The younger the child the less sensible it would be to speak of the place of habitual residence of the child as distinct from the place of habitual residence of the person or persons upon whom the child was immediately dependent for care and housing. However, this should not be elevated to a rule of dependency such as exists in respect of common law domicile.
The High Court held that the examination of a person's intentions would usually be relevant, and sometimes very important, to a consideration of where that person habitually resided. However, considerations relevant to deciding where a person was habitually resident were not necessarily confined to physical presence and intention, and intention was not to be given controlling weight.
It was further noted that intentions could be ambiguous. Consequently, in asking whether a person had abandoned residence in a place it was necessary to recognise the possibility that the person may not have formed a singular and irrevocable intention not to return, yet properly be described as no longer habitually resident in that place.
Absence of a final decision positively rejecting the possibility of returning (to Israel) in the foreseeable future was not necessarily inconsistent with (the children) ceasing to reside there habitually. In the case of children, attention could not be confined to the intentions of the parent who in fact had the day to day care. The High Court affirmed that there was not a closed set of criteria for ascertaining a person's habitual residence, or indeed a predetermined weighting between criteria.
Reviewing existing case law the High Court held that insofar as a settled intention was needed, it did not need to be a settled intention to take up "long term" residence, rather it sufficed that the purpose had a sufficient degree of continuity to be described as settled.
It further suggested that there was no disconformity between the approach of the New Zealand courts and the need, identified by Lord Brandon in Re J. (A Minor) (Abduction: Custody Rights)  2 AC 562 [INCADAT Reference: HC/E/UKe 2], to decide the question of habitual residence "by reference to all the circumstances of any particular case". The latter was also held to be a common thread in leading US decisions.
On the facts the Court held that the decisive factor was that when the children left Israel both parents agreed that unless there was a reconciliation, they would stay in Australia; the mother, both before and after departure, set about effecting that shared intention.
The possibility that the children might again take up habitual residence in Israel (if their parents were reconciled) did not prevent the loss of their habitual residence there meanwhile. The High Court held that it was not necessary to decide if the children had actually acquired a habitual residence in Australia.
La demande concernait quatre garçons âgés de 10, 7, 5 et 3 ans lors de l'audience d'appel. Jusqu'en mai 2006, ces enfants avaient vécu en Israël avec leurs parents, qui étaient mariés. La mère était australienne et avait suivi son mari en Israël.
En 2005, des difficultés survinrent au sein du couple. Le père quitta le foyer familial en septembre 2005. Le 16 mai 2006, la mère et les enfants gagnèrent l'Australie. Ils furent conduits à l'aéroport par le père ; des billets étaient réservés pour un retour en Israël le 27 août 2006.
Les enfants débutèrent leur scolarité à Sydney le 30 mai 2006. Les parents ne s'accordaient pas sur les conditions dans lesquelles la mère avait quitté Israël avec les enfants. La mère affirmait qu'elle restait sur l'idée que si le père lui signifiait que leur mariage était fini, elle ne rentrerait pas en Israël mais s'installerait de manière permanente avec les enfants en Australie.
Quant au père, il soutenait que la mère n'avait quitté Israël que pour une période déterminée et qu'il n'avait jamais consenti à ce que ses enfants restent loin d'Israël de façon permanente. En juin 2006, les parents évoquèrent la possibilité d'un divorce. La mère déclara que le père avait affirmé qu'elle et les enfants pouvaient rester en Australie. A cette période, elle lui dit qu'elle devait rester en Australie pour le reste de l'année civile afin de réfléchir à leur situation.
La mère ne retourna pas en Israël avec les enfants le 27 août 2006, comme il était convenu. Le père tenta de trouver un accord pour obtenir leur retour, mais n'y parvint pas. Il invoqua alors ses droits en application de la Convention. Le 29 août 2007, la Family Court of Australia ordonna le retour des enfants, sous réserve d'engagements :  FAMCA 1099.
L'appel interjeté par la mère fut rejeté par la Full Court of the Family Court of Australia qui ordonna le retour des enfants. Leur non-retour était illicite car les enfants n'avaient ni perdu leur résidence habituelle israélienne à la date pertinente, ni acquis une résidence habituelle en Australie.
Par ailleurs, le retour n'exposait pas les enfants à un risque grave de danger. Bien que le père ait dans un premier temps consenti à l'installation dans un autre pays, le juge avait correctement exercé son pouvoir d'ordonner le retour. La mère interjeta appel devant la High Court.
Recours accueilli et demande rejetée ; le non-retour n'était pas illicite car les enfants avaient perdu leur résidence habituelle israëlienne au moment du déplacement.
La High Court a relevé que dans le premier recours Kilah v. Director-General, Department of Community Services  FamCAFC 81 [Référence INCADAT : HC / E / AU 995] la Full Court of the Family Court of Australia avait considéré que l' « intention bien arrêtée » ou « la ferme volonté » qu'avait la mère d'intégrer ses enfants à la vie en Australie constituait une part nécessaire et intégrante à la détermination de la résidence habituelle des enfants.
La High Court jugea que la Full Court n'aurait pas dû traiter l'absence d'une ferme volonté d'abandonner la résidence habituelle israëlienne comme le facteur déterminant.
Pour parvenir à cette position, la High Court examina l'évolution de la résidence habituelle ainsi que la jurisprudence et la doctrine relatives au facteur de rattachement. Cette juridiction admit que la démarche consistant à aborder le concept simplement comme une question de fait présentait des restrictions. Elle considéra que les critères devant être retenus comme pertinents pour donner sens à l'expression « résidence habituelle » résidaient dans le « sens ordinaire du mot composé » et que l'on ne pouvait concevoir de définition plus précise.
La High Court admit que, dans certains situations, certes peu probables, une personne pouvait disposer de plus d'une résidence habituelle. Cependant, il était évident qu'une personne pouvait se trouver sans résidence habituelle à un moment donné, après avoir abandonné sa résidence habituelle sans en avoir acquis une autre.
Pour déterminer la résidence habituelle d'un enfant, il convenait de prêter attention au contexte dans lequel l'enquête était menée. En l'espèce, la Convention de La Haye visait à faciliter le règlement des différends entre parents concernant les soins d'un enfant, son bien-être et son développement en un for (le lieu de résidence habituelle) plutôt qu'un autre.
Il serait généralement très important d'examiner le lieu où la personne (ou les personnes) qui s'occupait de l'enfant avait leur résidence habituelle. Plus l'enfant est jeune et moins il serait difficile de parler du lieu de résidence habituelle de l'enfant comme distinct du lieu de résidence habituelle de la personne ou des personnes dont l'enfant dépend immédiatement pour ses soins et son logement. Toutefois, cette considération ne devrait pas être élevée au rang de règle de dépendance telle que le prévoit le concept anglo-saxon de domicile.
La High Court a considéré qu'il était habituellement pertinent, voire parfois très important, d'examiner les intentions d'une personne pour déterminer l'endroit où cette personne résidait habituellement. Les considérations pertinentes pour déterminer si une personne avait sa résidence habituelle à un endroit n'étaient toutefois pas nécessairement limitées à la présence physique et à l'intention. En ce sens, il ne convenait pas de donner un poids prépondérant à ce dernier facteur.
En outre, il a été relevé que les intentions des personnes pouvaient présenter un caractère ambigü. En conséquence, tout en se demandant si une personne avait abandonné sa résidence dans un lieu, il fallait nécessairement prendre en compte la possibilité que cette personne ait pu ne pas avoir formé une intention singulière et irrévocable de ne pas revenir, tout en étant encore décrite comme n'ayant plus sa résidence habituelle dans cet endroit.
L'absence d'une décision finale rejetant absolument la possibilité d'un retour (en Israël) dans un avenir prévisible n'était pas nécessairement incompatible avec le fait (pour les enfants) de cesser d'y résider habituellement. Dans le cas d'enfants, on ne pouvait prêter attention uniquement aux intentions du parent qui s'en occupait à titre principal. La High Court affirma qu'il était impossible de fixer une liste exhaustive de critères visant à déterminer la résidence habituelle d'une personne, ou une pondération prédéterminée entre les critères.
Après avoir examiné la jurisprudence existante, la High Court considéra que, si une intention bien arrêtée était nécessaire, celle-ci n'avait pas à être une ferme intention d'établir sa résidence sur le « long terme ». Il suffisait plutôt que la volonté présente un degré suffisant de continuité pour être décrite comme ferme.
Elle suggéra en outre qu'il n'y avait aucune discordance entre l'approche des tribunaux néo-zélandais et la nécessité, identifiée par le juge Brandon dans l'affaire Re J. (A Minor) (Abduction: Custody Rights)  2 AC 562 [Référence INCADAT : HC/E/UKe 2], de trancher la question de la résidence habituelle « en référence à toutes les circonstances de chaque cas particulier ». Cette question a également été considérée comme un fil conducteur des décisions américaines de premier plan.
Après examen des faits, la Cour considéra comme facteur décisif le fait que les deux parents étaient d'accord, lors du départ d'Israël, pour que la mère et les enfants restent en Australie, à moins d'une réconciliation. Avant et après le départ, la mère s'est toujours proposée de respecter cette intention commune.
La possibilité pour les enfants de retrouver leur résidence habituelle en Israël (si leurs parents se réconciliaient) n'a pas empêché la perte de leur résidence habituelle dans ce pays. La High Court considéra qu'il n'était pas nécessaire de décider si les enfants avaient effectivement acquis une résidence habituelle en Australie.

matches: v. v. v. v. v. v. v.


text:
Legge A, Kirkland S, Rockwood K, Andreou P, Bae SC, Gordon C, Romero-Diaz J, Sanchez-Guerrero J, Wallace DJ, Bernatsky S, Clarke AE, Merrill JT, Ginzler EM, Fortin P, Gladman DD, Urowitz MB, Bruce IN, Isenberg DA, Rahman A, Alarcón GS, Petri M, Khamashta MA, Dooley MA, Ramsey-Goldman R, Manzi S, Steinsson K, Zoma AA, Aranow C, Mackay M, Ruiz-Irastorza G, Lim SS, Inanc M, van Vollenhoven RF, Jonsen A, Nived O, Ramos-Casals M, Kamen DL, Kalunian KC, Jacobsen S, Peschken CA, Askanase A, Hanly JG. Evaluating the properties of a frailty index and its association with mortality risk among patients with systemic lupus erythematosus. Arthritis Rheumatol. 2019 Feb 16. PMID: 30771242.
Mendel A, Bernatsky S, Pineau CA, St-Pierre Y, Hanly JG, Urowitz MB, Clarke AE, Romero-Diaz J, Gordon C, Bae SC, Wallace DJ, Merrill JT, Buyon J, Isenberg DA, Rahman A, Ginzler EM, Petri M, Dooley MA, Fortin P, Gladman DD, Steinsson K, Ramsey-Goldman R, Khamashta MA, Aranow C, Mackay M, Alarcón G, Manzi S, Nived O, Jönsen A, Zoma AA, van Vollenhoven RF, Ramos-Casals M, Ruiz-Irastorza G, Lim S, Kalunian KC, Inanc M, Kamen DL, Peschken CA, Jacobsen S, Askanase A, Sanchez-Guerrero J, Bruce IN, Costedoat-Chalumeau N, Vinet E. Use of combined hormonal contraceptives among women with systemic lupus erythematosus with and without medical contraindications to oestrogen. Rheumatology (Oxford). 2019 Feb 08. PMID: 30753683.
Wirestam L, Enocsson H, Skogh T, Padyukov L, Jönsen A, Urowitz MB, Gladman DD, Romero-Diaz J, Bae SC, Fortin PR, Sanchez-Guerrero J, Clarke AE, Bernatsky S, Gordon C, Hanly JG, Wallace D, Isenberg DA, Rahman A, Merrill J, Ginzler E, Alarcón GS, Chatham WW, Petri M, Khamashta M, Aranow C, Mackay M, Dooley MA, Manzi S, Ramsey-Goldman R, Nived O, Steinsson K, Zoma A, Ruiz-Irastorza G, Lim S, Kalunian K, Inanc M, Vollenhoven RV, Ramos-Casals M, Kamen DL, Jacobsen S, Peschken C, Askanase A, Stoll T, Bruce IN, Wetterö J, Sjöwall C. Osteopontin and Disease Activity in Patients with Recent-onset Systemic Lupus Erythematosus: Results from the SLICC Inception Cohort. J Rheumatol. 2019 Jan 15. PMID: 30647177.
Ike R, Baskaran A, Chao J, Concoff AL, Wu CW, Sun B, Brion PH, Arnold EL, Klashman DJ, FitzGerald J, Kalunian KC. Prevalence of Crystals in Knee Osteoarthritis: Experience From Patients Undergoing Arthroscopic Procedures. J Clin Rheumatol. 2019 Jan; 25(1):51-53. PMID: 29517555.
Mendel A, Bernatsky SB, Hanly JG, Urowitz MB, Clarke AE, Romero-Diaz J, Gordon C, Bae SC, Wallace DJ, Merrill JT, Buyon JP, Isenberg DA, Rahman A, Ginzler EM, Petri M, Dooley MA, Fortin PR, Gladman DD, Steinsson K, Ramsey-Goldman R, Khamashta MA, Aranow C, Mackay M, Alarcón GS, Manzi S, Nived O, Jönsen A, Zoma AA, van Vollenhoven RF, Ramos-Casals M, Ruiz-Irastorza G, Lim S, Kalunian KC, Inanc M, Kamen DL, Peschken CA, Jacobsen S, Askanase A, Sanchez-Guerrero J, Bruce IN, Costedoat-Chalumeau N, Vinet É. Low aspirin use and high prevalence of pre-eclampsia risk factors among pregnant women in a multinational SLE inception cohort. Ann Rheum Dis. 2018 Dec 20. PMID: 30573656.
Hanly JG, Li Q, Su L, Urowitz MB, Gordon C, Bae SC, Romero-Diaz J, Sanchez-Guerrero J, Bernatsky S, Clarke AE, Wallace DJ, Isenberg DA, Rahman A, Merrill JT, Fortin PR, Gladman DD, Bruce IN, Petri M, Ginzler EM, Dooley MA, Steinsson K, Ramsey-Goldman R, Zoma AA, Manzi S, Nived O, Jonsen A, Khamashta MA, Alarcón GS, van Vollenhoven RF, Aranow C, Mackay M, Ruiz-Irastorza G, Ramos-Casals M, Lim SS, Inanc M, Kalunian KC, Jacobsen S, Peschken CA, Kamen DL, Askanase A, Theriault C, Farewell V. Psychosis in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study. Arthritis Rheumatol. 2018 Oct 30. PMID: 30375754.
Mackay M, Dall'Era M, Fishbein J, Kalunian K, Lesser M, Sanchez Guerrero J, Levy DM, Silverman E, Petri M, Arriens C, Lewis EJ, Korbet SM, Conti F, Tesar V, Hruskova Z, Borba EF, Bonfa E, Chan TM, Rathi M, Gupta KL, Jha V, Hasni S, West MR, Silverman E, Solomons N, Houssiau FA, Romera Diaz J, Mejia-Vilet J, Rovin BH. Establishing Surrogate Kidney Endpoints for Lupus Nephritis Clinical Trials: Development and Validation of a Novel Approach to Predict Future Kidney Outcomes. Arthritis Rheumatol. 2018 Sep 17. PMID: 30225865.
Hanly JG, Li Q, Su L, Urowitz MB, Gordon C, Bae SC, Romero-Diaz J, Sanchez-Guerrero J, Bernatsky S, Clarke AE, Wallace DJ, Isenberg DA, Rahman A, Merrill JT, Fortin P, Gladman DD, Bruce IN, Petri M, Ginzler EM, Dooley MA, Steinsson K, Ramsey-Goldman R, Zoma AA, Manzi S, Nived O, Jonsen A, Khamashta MA, Alarcón GS, Chatham W, van Vollenhoven RF, Aranow C, Mackay M, Ruiz-Irastorza G, Ramos-Casals M, Lim SS, Inanc M, Kalunian KC, Jacobsen S, Peschken CA, Kamen DL, Askanase A, Theriault C, Farewell V. Cerebrovascular Events in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study. Arthritis Care Res (Hoboken). 2018 Oct; 70(10):1478-1487. PMID: 29316357.
Barber MRW, Hanly JG, Su L, Urowitz MB, St Pierre Y, Romero-Diaz J, Gordon C, Bae SC, Bernatsky S, Wallace DJ, Isenberg DA, Rahman A, Ginzler EM, Petri M, Bruce IN, Fortin PR, Gladman DD, Sanchez-Guerrero J, Ramsey-Goldman R, Khamashta MA, Aranow C, Mackay M, Alarcón GS, Manzi S, Nived O, Jönsen A, Zoma AA, van Vollenhoven RF, Ramos-Casals M, Ruiz-Irastorza G, Lim SS, Kalunian KC, Inanc M, Kamen DL, Peschken CA, Jacobsen S, Askanase A, Theriault C, Farewell V, Clarke AE. Economic Evaluation of Lupus Nephritis in the Systemic Lupus International Collaborating Clinics Inception Cohort Using a Multistate Model Approach. Arthritis Care Res (Hoboken). 2018 Sep; 70(9):1294-1302. PMID: 29193883.
Kim M, Merrill JT, Kalunian K, Hanrahan L, Izmirly P. Evaluating duration of response to treatment in systemic lupus erythematosus clinical trials. Lupus Sci Med. 2018; 5(1):e000266. PMID: 30319781.
Choi MY, Clarke AE, St Pierre Y, Hanly JG, Urowitz MB, Romero-Diaz J, Gordon C, Bae SC, Bernatsky S, Wallace DJ, Merrill JT, Isenberg DA, Rahman A, Ginzler EM, Petri M, Bruce IN, Dooley MA, Fortin PR, Gladman DD, Sanchez-Guerrero J, Steinsson K, Ramsey-Goldman R, Khamashta MA, Aranow C, Alarcón GS, Manzi S, Nived O, Zoma AA, van Vollenhoven RF, Ramos-Casals M, Ruiz-Irastorza G, Lim SS, Kalunian KC, Inanc M, Kamen DL, Peschken CA, Jacobsen S, Askanase A, Stoll T, Buyon J, Mahler M, Fritzler MJ. Antinuclear Antibody-Negative Systemic Lupus Erythematosus in an International Inception Cohort. Arthritis Care Res (Hoboken). 2018 Jul 25. PMID: 30044551.
Wallace DJ, Furie RA, Tanaka Y, Kalunian KC, Mosca M, Petri MA, Dörner T, Cardiel MH, Bruce IN, Gomez E, Carmack T, DeLozier AM, Janes JM, Linnik MD, de Bono S, Silk ME, Hoffman RW. Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 2 trial. Lancet. 2018 07 21; 392(10143):222-231. PMID: 30043749.
Anastasiou C, Dulai O, Baskaran A, Proudfoot J, Verhaegen S, Kalunian K. Immunosuppressant use and hospitalisations in adult patients with systemic lupus erythematosus admitted to a tertiary academic medical centre. Lupus Sci Med. 2018; 5(1):e000249. PMID: 29955368.
Merrill JT, Petri MA, Buyon J, Ramsey-Goldman R, Kalunian K, Putterman C, Conklin J, Furie RA, Dervieux T. Erythrocyte-bound C4d in combination with complement and autoantibody status for the monitoring of SLE. Lupus Sci Med. 2018; 5(1):e000263. PMID: 29868177.
Little J, Parker B, Lunt M, Hanly JG, Urowitz MB, Clarke AE, Romero-Diaz J, Gordon C, Bae SC, Bernatsky S, Wallace DJ, Merrill JT, Buyon J, Isenberg DA, Rahman A, Ginzler EM, Petri M, Dooley MA, Fortin P, Gladman DD, Steinsson K, Ramsey-Goldman R, Khamashta MA, Aranow C, Mackay M, Alarcón GS, Manzi S, Nived O, Jönsen A, Zoma AA, van Vollenhoven RF, Ramos-Casals M, Ruiz-Irastorza G, Sam Lim S, Kalunian KC, Inanc M, Kamen DL, Peschken CA, Jacobsen S, Askanase A, Sanchez-Guerrero J, Bruce IN. Glucocorticoid use and factors associated with variability in this use in the Systemic Lupus International Collaborating Clinics Inception Cohort. Rheumatology (Oxford). 2018 04 01; 57(4):677-687. PMID: 29361147.
Merrill JT, Manzi S, Aranow C, Askenase A, Bruce I, Chakravarty E, Chong B, Costenbader K, Dall'Era M, Ginzler E, Hanrahan L, Kalunian K, Merola J, Raymond S, Rovin B, Saxena A, Werth VP. Lupus community panel proposals for optimising clinical trials: 2018. Lupus Sci Med. 2018; 5(1):e000258. PMID: 29657738.
Ike RW, Kalunian KC. Arthroscopy in Rheumatology: Time for a New Look? J Rheumatol. 2018 Mar; 45(3):300-301. PMID: 29496915.
Kalunian KC, Urowitz MB, Isenberg D, Merrill JT, Petri M, Furie RA, Morgan-Cox MA, Taha R, Watts S, Silk M, Linnik MD. Clinical trial parameters that influence outcomes in lupus trials that use the systemic lupus erythematosus responder index. Rheumatology (Oxford). 2018 01 01; 57(1):125-133. PMID: 29045736.
Ferreira I, Croca S, Raimondo MG, Matharu M, Miller S, Giles I, Isenberg D, Ioannou Y, Hanly JG, Urowitz MB, Anderson N, Aranow C, Askanase A, Bae SC, Bernatsky S, Bruce IN, Buyon J, Clarke AE, Dooley MA, Fortin P, Ginzler E, Gladman D, Gordon C, Inanc M, Jacobsen S, Kalunian K, Kamen D, Khamashta M, Lim S, Manzi S, Merrill J, Nived O, Peschken C, Petri M, Ramsey-Goldman R, Ruiz-Irastorza G, Sanchez-Guerrero J, Steinson K, Sturfelt GK, van Vollenhoven R, Wallace DJ, Zoma A, Rahman A. Nitrated nucleosome levels and neuropsychiatric events in systemic lupus erythematosus; a multi-center retrospective case-control study. Arthritis Res Ther. 2017 Dec 22; 19(1):287. PMID: 29273092.
Kim M, Merrill J, Kalunian K, Hahn B, Roach A, Izmirly P. Brief Report: Longitudinal Patterns of Response to Standard of Care Therapy for Systemic Lupus Erythematosus: Implications for Clinical Trial Design. Arthritis Rheumatol. 2017 04; 69(4):785-790. PMID: 27992696.
Clowse ME, Wallace DJ, Furie RA, Petri MA, Pike MC, Leszczynski P, Neuwelt CM, Hobbs K, Keiserman M, Duca L, Kalunian KC, Galateanu C, Bongardt S, Stach C, Beaudot C, Kilgallen B, Gordon C. Efficacy and Safety of Epratuzumab in Moderately to Severely Active Systemic Lupus Erythematosus: Results From Two Phase III Randomized, Double-Blind, Placebo-Controlled Trials. Arthritis Rheumatol. 2017 02; 69(2):362-375. PMID: 27598855.
Furie R, Khamashta M, Merrill JT, Werth VP, Kalunian K, Brohawn P, Illei GG, Drappa J, Wang L, Yoo S. Anifrolumab, an Anti-Interferon-a Receptor Monoclonal Antibody, in Moderate-to-Severe Systemic Lupus Erythematosus. Arthritis Rheumatol. 2017 02; 69(2):376-386. PMID: 28130918.
Buyon J, Furie R, Putterman C, Ramsey-Goldman R, Kalunian K, Barken D, Conklin J, Dervieux T. Reduction in erythrocyte-bound complement activation products and titres of anti-C1q antibodies associate with clinical improvement in systemic lupus erythematosus. Lupus Sci Med. 2016; 3(1):e000165. PMID: 27752336.
Kalunian KC. Interferon-targeted therapy in systemic lupus erythematosus: Is this an alternative to targeting B and T cells? Lupus. 2016 Sep; 25(10):1097-101. PMID: 27497254.
Hanly JG, Su L, Urowitz MB, Romero-Diaz J, Gordon C, Bae SC, Bernatsky S, Clarke AE, Wallace DJ, Merrill JT, Isenberg DA, Rahman A, Ginzler EM, Petri M, Bruce IN, Dooley MA, Fortin P, Gladman DD, Sanchez-Guerrero J, Steinsson K, Ramsey-Goldman R, Khamashta MA, Aranow C, Alarcón GS, Fessler BJ, Manzi S, Nived O, Sturfelt GK, Zoma AA, van Vollenhoven RF, Ramos-Casals M, Ruiz-Irastorza G, Lim SS, Kalunian KC, Inanc M, Kamen DL, Peschken CA, Jacobsen S, Askanase A, Theriault C, Farewell V. A Longitudinal Analysis of Outcomes of Lupus Nephritis in an International Inception Cohort Using a Multistate Model Approach. Arthritis Rheumatol. 2016 08; 68(8):1932-44. PMID: 26991067.
Kalunian KC. Current advances in therapies for osteoarthritis. Curr Opin Rheumatol. 2016 May; 28(3):246-50. PMID: 27022820.
Khamashta M, Merrill JT, Werth VP, Furie R, Kalunian K, Illei GG, Drappa J, Wang L, Greth W. Sifalimumab, an anti-interferon-a monoclonal antibody, in moderate to severe systemic lupus erythematosus: a randomised, double-blind, placebo-controlled study. Ann Rheum Dis. 2016 Nov; 75(11):1909-1916. PMID: 27009916.
Kalunian KC, Kim M, Xie X, Baskaran A, Daly RP, Merrill JT. Impact of standard of care treatments and disease variables on outcomes in systemic lupus erythematosus trials: analysis from the Lupus Foundation of America Collective Data Analysis Initiative. Eur J Rheumatol. 2016 Mar; 3(1):13-19. PMID: 27708963.
Hanly JG, O'Keeffe AG, Su L, Urowitz MB, Romero-Diaz J, Gordon C, Bae SC, Bernatsky S, Clarke AE, Wallace DJ, Merrill JT, Isenberg DA, Rahman A, Ginzler EM, Fortin P, Gladman DD, Sanchez-Guerrero J, Petri M, Bruce IN, Dooley MA, Ramsey-Goldman R, Aranow C, Alarcón GS, Fessler BJ, Steinsson K, Nived O, Sturfelt GK, Manzi S, Khamashta MA, van Vollenhoven RF, Zoma AA, Ramos-Casals M, Ruiz-Irastorza G, Lim SS, Stoll T, Inanc M, Kalunian KC, Kamen DL, Maddison P, Peschken CA, Jacobsen S, Askanase A, Theriault C, Thompson K, Farewell V. The frequency and outcome of lupus nephritis: results from an international inception cohort study. Rheumatology (Oxford). 2016 Feb; 55(2):252-62. PMID: 26342222; PMCID: PMC4939728 [Available on 02/01/17].
Hanly JG, Su L, Urowitz MB, Romero-Diaz J, Gordon C, Bae SC, Bernatsky S, Clarke AE, Wallace DJ, Merrill JT, Isenberg DA, Rahman A, Ginzler EM, Petri M, Bruce IN, Dooley MA, Fortin P, Gladman DD, Sanchez-Guerrero J, Steinsson K, Ramsey-Goldman R, Khamashta MA, Aranow C, Alarcón GS, Fessler BJ, Manzi S, Nived O, Sturfelt GK, Zoma AA, van Vollenhoven RF, Ramos-Casals M, Ruiz-Irastorza G, Lim SS, Kalunian KC, Inanc M, Kamen DL, Peschken CA, Jacobsen S, Askanase A, Theriault C, Thompson K, Farewell V. Mood Disorders in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study. Arthritis Rheumatol. 2015 Jul; 67(7):1837-47. PMID: 25778456; PMCID: PMC4485527.
Kalunian KC, Merrill JT, Maciuca R, McBride JM, Townsend MJ, Wei X, Davis JC, Kennedy WP. A Phase II study of the efficacy and safety of rontalizumab (rhuMAb interferon-a) in patients with systemic lupus erythematosus (ROSE). Ann Rheum Dis. 2016 Jan; 75(1):196-202. PMID: 26038091.
Utset TO, Baskaran A, Segal BM, Trupin L, Ogale S, Herberich E, Kalunian K. Work disability, lost productivity and associated risk factors in patients diagnosed with systemic lupus erythematosus. Lupus Sci Med. 2015; 2(1):e000058. PMID: 25632349; PMCID: PMC4305073.
Bourré-Tessier J, Urowitz MB, Clarke AE, Bernatsky S, Krantz MJ, Huynh T, Joseph L, Belisle P, Bae SC, Hanly JG, Wallace DJ, Gordon C, Isenberg D, Rahman A, Gladman DD, Fortin PR, Merrill JT, Romero-Diaz J, Sanchez-Guerrero J, Fessler B, Alarcón GS, Steinsson K, Bruce IN, Ginzler E, Dooley MA, Nived O, Sturfelt G, Kalunian K, Ramos-Casals M, Petri M, Zoma A, Pineau CA. Electrocardiographic findings in systemic lupus erythematosus: data from an international inception cohort. Arthritis Care Res (Hoboken). 2015 Jan; 67(1):128-35. PMID: 24838943.
Putterman C, Furie R, Ramsey-Goldman R, Askanase A, Buyon J, Kalunian K, Chatham WW, Massarotti E, Kirou K, Jordan N, Blanco I, Weinstein A, Chitkara P, Manzi S, Ahearn J, O'Malley T, Conklin J, Ibarra C, Barken D, Dervieux T. Cell-bound complement activation products in systemic lupus erythematosus: comparison with anti-double-stranded DNA and standard complement measurements. Lupus Sci Med. 2014; 1(1):e000056. PMID: 25396070; PMCID: PMC4225732.
Lertratanakul A, Wu P, Dyer A, Urowitz M, Gladman D, Fortin P, Bae SC, Gordon C, Clarke A, Bernatsky S, Hanly JG, Isenberg D, Rahman A, Merrill J, Wallace DJ, Ginzler E, Khamashta M, Bruce I, Nived O, Sturfelt G, Steinsson K, Manzi S, Dooley MA, Kalunian K, Petri M, Aranow C, Font J, van Vollenhoven R, Stoll T, Ramsey-Goldman R. 25-hydroxyvitamin D and cardiovascular disease in patients with systemic lupus erythematosus: data from a large international inception cohort. Arthritis Care Res (Hoboken). 2014 Aug; 66(8):1167-76. PMID: 24470118.
Bruce IN, O'Keeffe AG, Farewell V, Hanly JG, Manzi S, Su L, Gladman DD, Bae SC, Sanchez-Guerrero J, Romero-Diaz J, Gordon C, Wallace DJ, Clarke AE, Bernatsky S, Ginzler EM, Isenberg DA, Rahman A, Merrill JT, Alarcón GS, Fessler BJ, Fortin PR, Petri M, Steinsson K, Dooley MA, Khamashta MA, Ramsey-Goldman R, Zoma AA, Sturfelt GK, Nived O, Aranow C, Mackay M, Ramos-Casals M, van Vollenhoven RF, Kalunian KC, Ruiz-Irastorza G, Lim S, Kamen DL, Peschken CA, Inanc M, Urowitz MB. Factors associated with damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort. Ann Rheum Dis. 2015 Sep; 74(9):1706-13. PMID: 24834926; PMCID: PMC4552899.
Parker B, Urowitz MB, Gladman DD, Lunt M, Donn R, Bae SC, Sanchez-Guerrero J, Romero-Diaz J, Gordon C, Wallace DJ, Clarke AE, Bernatsky S, Ginzler EM, Isenberg DA, Rahman A, Merrill JT, Alarcón GS, Fessler BJ, Fortin PR, Hanly JG, Petri M, Steinsson K, Dooley MA, Manzi S, Khamashta MA, Ramsey-Goldman R, Zoma AA, Sturfelt GK, Nived O, Aranow C, Mackay M, Ramos-Casals M, van Vollenhoven RF, Kalunian KC, Ruiz-Irastorza G, Lim SS, Kamen DL, Peschken CA, Inanc M, Bruce IN. Impact of early disease factors on metabolic syndrome in systemic lupus erythematosus: data from an international inception cohort. Ann Rheum Dis. 2015 Aug; 74(8):1530-6. PMID: 24692585; PMCID: PMC4515988.
Ceponis A, Onishi M, Bluestein HG, Kalunian K, Townsend J, Kavanaugh A. Utility of the ultrasound examination of the hand and wrist joints in the management of established rheumatoid arthritis. Arthritis Care Res (Hoboken). 2014 Feb; 66(2):236-44. PMID: 23983173.
Strand V, Petri M, Kalunian K, Gordon C, Wallace DJ, Hobbs K, Kelley L, Kilgallen B, Wegener WA, Goldenberg DM. Epratuzumab for patients with moderate to severe flaring SLE: health-related quality of life outcomes and corticosteroid use in the randomized controlled ALLEVIATE trials and extension study SL0006. Rheumatology (Oxford). 2014 Mar; 53(3):502-11. PMID: 24273022; PMCID: PMC3930886.
Hanly JG, Urowitz MB, O'Keeffe AG, Gordon C, Bae SC, Sanchez-Guerrero J, Romero-Diaz J, Clarke AE, Bernatsky S, Wallace DJ, Ginzler EM, Isenberg DA, Rahman A, Merrill JT, Petri M, Fortin PR, Gladman DD, Fessler BJ, Alarcón GS, Bruce IN, Dooley MA, Steinsson K, Khamashta MA, Ramsey-Goldman R, Manzi S, Sturfelt GK, Nived O, Zoma AA, van Vollenhoven RF, Ramos-Casals M, Aranow C, Mackay M, Ruiz-Irastorza G, Kalunian KC, Lim SS, Inanc M, Kamen DL, Peschken CA, Jacobsen S, Theriault C, Thompson K, Farewell V. Headache in systemic lupus erythematosus: results from a prospective, international inception cohort study. Arthritis Rheum. 2013 Nov; 65(11):2887-97. PMID: 24166793.
Petri M, Wallace DJ, Spindler A, Chindalore V, Kalunian K, Mysler E, Neuwelt CM, Robbie G, White WI, Higgs BW, Yao Y, Wang L, Ethgen D, Greth W. Sifalimumab, a human anti-interferon-a monoclonal antibody, in systemic lupus erythematosus: a phase I randomized, controlled, dose-escalation study. Arthritis Rheum. 2013 Apr; 65(4):1011-21. PMID: 23400715; PMCID: PMC3654174.
Wallace DJ, Gordon C, Strand V, Hobbs K, Petri M, Kalunian K, Houssiau F, Tak PP, Isenberg DA, Kelley L, Kilgallen B, Barry AN, Wegener WA, Goldenberg DM. Efficacy and safety of epratuzumab in patients with moderate/severe flaring systemic lupus erythematosus: results from two randomized, double-blind, placebo-controlled, multicentre studies (ALLEVIATE) and follow-up. Rheumatology (Oxford). 2013 Jul; 52(7):1313-22. PMID: 23542611.
Wallace DJ, Kalunian K, Petri MA, Strand V, Houssiau FA, Pike M, Kilgallen B, Bongardt S, Barry A, Kelley L, Gordon C. Efficacy and safety of epratuzumab in patients with moderate/severe active systemic lupus erythematosus: results from EMBLEM, a phase IIb, randomised, double-blind, placebo-controlled, multicentre study. Ann Rheum Dis. 2014 Jan; 73(1):183-90. PMID: 23313811.
Kalunian KC, Chatham WW, Massarotti EM, Reyes-Thomas J, Harris C, Furie RA, Chitkara P, Putterman C, Gross RL, Somers EC, Kirou KA, Ramsey-Goldman R, Hsieh C, Buyon JP, Dervieux T, Weinstein A. Measurement of cell-bound complement activation products enhances diagnostic performance in systemic lupus erythematosus. Arthritis Rheum. 2012 Dec; 64(12):4040-7. PMID: 22932861.
Parker B, Urowitz MB, Gladman DD, Lunt M, Bae SC, Sanchez-Guerrero J, Romero-Diaz J, Gordon C, Wallace DJ, Clarke AE, Bernatsky S, Ginzler EM, Isenberg DA, Rahman A, Merrill JT, Alarcón GS, Fessler BJ, Fortin PR, Hanly JG, Petri M, Steinsson K, Dooley MA, Manzi S, Khamashta MA, Ramsey-Goldman R, Zoma AA, Sturfelt GK, Nived O, Aranow C, Mackay M, Ramos-Casals M, van Vollenhoven RF, Kalunian KC, Ruiz-Irastorza G, Lim S, Kamen DL, Peschken CA, Inanc M, Bruce IN. Clinical associations of the metabolic syndrome in systemic lupus erythematosus: data from an international inception cohort. Ann Rheum Dis. 2013 Aug; 72(8):1308-14. PMID: 22945501; PMCID: PMC3711497.
Petri M, Orbai AM, Alarcón GS, Gordon C, Merrill JT, Fortin PR, Bruce IN, Isenberg D, Wallace DJ, Nived O, Sturfelt G, Ramsey-Goldman R, Bae SC, Hanly JG, Sánchez-Guerrero J, Clarke A, Aranow C, Manzi S, Urowitz M, Gladman D, Kalunian K, Costner M, Werth VP, Zoma A, Bernatsky S, Ruiz-Irastorza G, Khamashta MA, Jacobsen S, Buyon JP, Maddison P, Dooley MA, van Vollenhoven RF, Ginzler E, Stoll T, Peschken C, Jorizzo JL, Callen JP, Lim SS, Fessler BJ, Inanc M, Kamen DL, Rahman A, Steinsson K, Franks AG, Sigler L, Hameed S, Fang H, Pham N, Brey R, Weisman MH, McGwin G, Magder LS. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum. 2012 Aug; 64(8):2677-86. PMID: 22553077; PMCID: PMC3409311.
Hanly JG, Urowitz MB, Su L, Gordon C, Bae SC, Sanchez-Guerrero J, Romero-Diaz J, Wallace DJ, Clarke AE, Ginzler E, Merrill JT, Isenberg DA, Rahman A, Petri M, Fortin PR, Gladman D, Bruce IN, Steinsson K, Dooley M, Khamashta MA, Alarcón GS, Fessler BJ, Ramsey-Goldman R, Manzi S, Zoma AA, Sturfelt GK, Nived O, Aranow C, Mackay M, Ramos-Casals M, van Vollenhoven R, Kalunian KC, Ruiz-Irastorza G, Lim S, Kamen DL, Peschken CA, Inanc M, Theriault C, Thompson K, Farewell V. Seizure disorders in systemic lupus erythematosus results from an international, prospective, inception cohort study. Ann Rheum Dis. 2012 Sep; 71(9):1502-9. PMID: 22492779; PMCID: PMC4656036.
Rosengren S, Kalunian KC, Kavanaugh A, Boyle DL. CXCL13 as a marker for outcome of rheumatoid arthritis: comment on the article by Meeuwisse et al. Arthritis Rheum. 2011 Nov; 63(11):3646-7. PMID: 21834069.
Vinet E, Clarke AE, Gordon C, Urowitz MB, Hanly JG, Pineau CA, Isenberg D, Rahman A, Wallace D, Alarcón GS, Bruce I, Petri M, Dooley MA, Kalunian K, Maddison P, Aranow C, van Vollenhoven R, Bernatsky S. Decreased live births in women with systemic lupus erythematosus. Arthritis Care Res (Hoboken). 2011 Jul; 63(7):1068-72. PMID: 21425248.
Rosengren S, Wei N, Kalunian KC, Kavanaugh A, Boyle DL. CXCL13: a novel biomarker of B-cell return following rituximab treatment and synovitis in patients with rheumatoid arthritis. Rheumatology (Oxford). 2011 Mar; 50(3):603-10. PMID: 21098574.
Chao J, Wu C, Sun B, Hose MK, Quan A, Hughes TH, Boyle D, Kalunian KC. Inflammatory characteristics on ultrasound predict poorer longterm response to intraarticular corticosteroid injections in knee osteoarthritis. J Rheumatol. 2010 Mar; 37(3):650-5. PMID: 20080918.
Kalunian K, Merrill JT. New directions in the treatment of systemic lupus erythematosus. Curr Med Res Opin. 2009 Jun; 25(6):1501-14. PMID: 19435401.
Rosengren S, Wei N, Kalunian KC, Zvaifler NJ, Kavanaugh A, Boyle DL. Elevated autoantibody content in rheumatoid arthritis synovia with lymphoid aggregates and the effect of rituximab. Arthritis Res Ther. 2008; 10(5):R105. PMID: 18761748; PMCID: PMC2592782.
Chao J, Kalunian K. Ultrasonography in osteoarthritis: recent advances and prospects for the future. Curr Opin Rheumatol. 2008 Sep; 20(5):560-4. PMID: 18698178.
Chao J, Kalunian K. Osteoarthritis: is this a disease for biologics or the physiatrist? Curr Opin Rheumatol. 2008 Sep; 20(5):545-6. PMID: 18698175.
Petri M, Kasitanon N, Singh S, Link K, Magder L, Bae SC, Hanly JG, Nived O, Sturfelt G, van Vollenhoven R, Wallace DJ, Alarcón GS, Adu D, Avila-Casado C, Bernatsky SR, Bruce IN, Clarke AE, Contreras G, Fine DM, Gladman DD, Gordon C, Kalunian KC, Madaio MP, Rovin BH, Sanchez-Guerrero J, Steinsson K, Aranow C, Balow JE, Buyon JP, Ginzler EM, Khamashta MA, Urowitz MB, Dooley MA, Merrill JT, Ramsey-Goldman R, Font J, Tumlin J, Stoll T, Zoma A. Systemic lupus international collaborating clinics renal activity/response exercise: comparison of agreement in rating renal response. Arthritis Rheum. 2008 Jun; 58(6):1789-95. PMID: 18512814.
Petri M, Kasitanon N, Lee SS, Link K, Magder L, Bae SC, Hanly JG, Isenberg DA, Nived O, Sturfelt G, van Vollenhoven R, Wallace DJ, Alarcón GS, Adu D, Avila-Casado C, Bernatsky SR, Bruce IN, Clarke AE, Contreras G, Fine DM, Gladman DD, Gordon C, Kalunian KC, Madaio MP, Rovin BH, Sanchez-Guerrero J, Steinsson K, Aranow C, Balow JE, Buyon JP, Ginzler EM, Khamashta MA, Urowitz MB, Dooley MA, Merrill JT, Ramsey-Goldman R, Font J, Tumlin J, Stoll T, Zoma A. Systemic lupus international collaborating clinics renal activity/response exercise: development of a renal activity score and renal response index. Arthritis Rheum. 2008 Jun; 58(6):1784-8. PMID: 18512819.
Sun BH, Wu CW, Kalunian KC. New developments in osteoarthritis. Rheum Dis Clin North Am. 2007 Feb; 33(1):135-48. PMID: 17367697.
Cassell SE, Bieber JD, Rich P, Tutuncu ZN, Lee SJ, Kalunian KC, Wu CW, Kavanaugh A. The modified Nail Psoriasis Severity Index: validation of an instrument to assess psoriatic nail involvement in patients with psoriatic arthritis. J Rheumatol. 2007 Jan; 34(1):123-9. PMID: 17216680.
McMahon M, Grossman J, FitzGerald J, Dahlin-Lee E, Wallace DJ, Thong BY, Badsha H, Kalunian K, Charles C, Navab M, Fogelman AM, Hahn BH. Proinflammatory high-density lipoprotein as a biomarker for atherosclerosis in patients with systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum. 2006 Aug; 54(8):2541-9. PMID: 16868975.
Petri M, Kim MY, Kalunian KC, Grossman J, Hahn BH, Sammaritano LR, Lockshin M, Merrill JT, Belmont HM, Askanase AD, McCune WJ, Hearth-Holmes M, Dooley MA, Von Feldt J, Friedman A, Tan M, Davis J, Cronin M, Diamond B, Mackay M, Sigler L, Fillius M, Rupel A, Licciardi F, Buyon JP. Combined oral contraceptives in women with systemic lupus erythematosus. N Engl J Med. 2005 Dec 15; 353(24):2550-8. PMID: 16354891.
Wu CW, Morrell MR, Heinze E, Concoff AL, Wollaston SJ, Arnold EL, Singh R, Charles C, Skovrun ML, FitzGerald JD, Moreland LW, Kalunian KC. Validation of American College of Rheumatology classification criteria for knee osteoarthritis using arthroscopically defined cartilage damage scores. Semin Arthritis Rheum. 2005 Dec; 35(3):197-201. PMID: 16325660.
Wu CW, Kalunian KC. New developments in osteoarthritis. Clin Geriatr Med. 2005 Aug; 21(3):589-601, vii. PMID: 15911209.
Buyon JP, Petri MA, Kim MY, Kalunian KC, Grossman J, Hahn BH, Merrill JT, Sammaritano L, Lockshin M, Alarcón GS, Manzi S, Belmont HM, Askanase AD, Sigler L, Dooley MA, Von Feldt J, McCune WJ, Friedman A, Wachs J, Cronin M, Hearth-Holmes M, Tan M, Licciardi F. The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trial. Ann Intern Med. 2005 Jun 21; 142(12 Pt 1):953-62. PMID: 15968009.
Wu CW, Terkeltaub R, Kalunian KC. Calcium-containing crystals and osteoarthritis: implications for the clinician. Curr Rheumatol Rep. 2005 Jun; 7(3):213-9. PMID: 15918998.
Wu C, Kalunian K. Treatment of the antiphospholipid antibody syndrome. Curr Rheumatol Rep. 2004 Dec; 6(6):463-8. PMID: 15527706.
Wollaston SJ, Farewell VT, Isenberg DA, Gordon C, Merrill JT, Petri MA, Kalunian KC. Defining response in systemic lupus erythematosus: a study by the Systemic Lupus International Collaborating Clinics group. J Rheumatol. 2004 Dec; 31(12):2390-4. PMID: 15570639.
Petri MA, Mease PJ, Merrill JT, Lahita RG, Iannini MJ, Yocum DE, Ginzler EM, Katz RS, Gluck OS, Genovese MC, Van Vollenhoven R, Kalunian KC, Manzi S, Greenwald MW, Buyon JP, Olsen NJ, Schiff MH, Kavanaugh AF, Caldwell JR, Ramsey-Goldman R, St Clair EW, Goldman AL, Egan RM, Polisson RP, Moder KG, Rothfield NF, Spencer RT, Hobbs K, Fessler BJ, Calabrese LH, Moreland LW, Cohen SB, Quarles BJ, Strand V, Gurwith M, Schwartz KE. Effects of prasterone on disease activity and symptoms in women with active systemic lupus erythematosus. Arthritis Rheum. 2004 Sep; 50(9):2858-68. PMID: 15452837.
Tsao BP, Cantor RM, Grossman JM, Kim SK, Strong N, Lau CS, Chen CJ, Shen N, Ginzler EM, Goldstein R, Kalunian KC, Arnett FC, Wallace DJ, Hahn BH. Linkage and interaction of loci on 1q23 and 16q12 may contribute to susceptibility to systemic lupus erythematosus. Arthritis Rheum. 2002 Nov; 46(11):2928-36. PMID: 12428234.
Tsao BP, Grossman JM, Riemekasten G, Strong N, Kalsi J, Wallace DJ, Chen CJ, Lau CS, Ginzler EM, Goldstein R, Kalunian KC, Harley JB, Arnett FC, Hahn BH, Cantor RM. Familiality and co-occurrence of clinical features of systemic lupus erythematosus. Arthritis Rheum. 2002 Oct; 46(10):2678-85. PMID: 12384927.
Hahn BH, Grossman J, Kalunian K. Improving joint disease in patients with rheumatoid arthritis: is this enough to treat the accompanying dyslipidemias? Am J Med. 2002 Aug 15; 113(3):247-8. PMID: 12208388.
Hoffman GS, Cid MC, Hellmann DB, Guillevin L, Stone JH, Schousboe J, Cohen P, Calabrese LH, Dickler H, Merkel PA, Fortin P, Flynn JA, Locker GA, Easley KA, Schned E, Hunder GG, Sneller MC, Tuggle C, Swanson H, Hernández-Rodríguez J, Lopez-Soto A, Bork D, Hoffman DB, Kalunian K, Klashman D, Wilke WS, Scheetz RJ, Mandell BF, Fessler BJ, Kosmorsky G, Prayson R, Luqmani RA, Nuki G, McRorie E, Sherrer Y, Baca S, Walsh B, Ferland D, Soubrier M, Choi HK, Gross W, Segal AM, Ludivico C, Puechal X. A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis. Arthritis Rheum. 2002 May; 46(5):1309-18. PMID: 12115238.

matches: V. V. V. V. V. V. V.


§ 195-1 Adoption of map.
§ 195-2 Map to constitute official finding and record.
§ 195-3 Notification of changes in boundaries.
§ 195-4 Clerk to keep original on file; copies to be provided.
§ 195-5 Findings and determinations.
§ 195-6 Adoption of map.
§ 195-7 Map to constitute official finding and record.
§ 195-8 Clerk to keep original on file; copies to be provided.
§ 195-9 Findings and determinations.
In accordance with and pursuant to the authority of P.L. 1988, c. 44 (N.J.S.A. 2C:35-7), the Drug-Free School Zone Map produced in March 1988 by Heritage Consulting Engineers is hereby approved and adopted as an official finding and record of the location and areas within the municipality of property which is used for school purposes and which is owned by or leased to any elementary or secondary school or school board, and of the areas on or within 1,000 feet of such school property.
The Drug-Free School Zone Map approved and adopted pursuant to § 195-1 of this article shall continue to constitute an official finding and record as to the location and boundaries of areas on or within 1,000 feet of property owned by or leased to any elementary or secondary school or school board which is used for school purposes until such time, if any, that this article shall be amended to reflect any additions or deletions with respect to the location and boundaries of school property and drug-free school zones.
The Clerk of the municipality is hereby directed to receive and to keep on file the original of the map approved and adopted pursuant to § 195-1 of this article, and to provide at a reasonable cost a true copy thereof to any person, agency or court which may from time to time request such a copy, along with a certification that such copy is a true copy of the map approved and adopted herein and kept on file. It is hereby further directed that a true copy of such map and this article shall be provided without cost to the County Clerk and to the office of the Warren County Prosecutor.
Except as is otherwise noted on the face of the approved and adopted map, all of the property depicted on the map approved and adopted herein as school property was owned by or leased to a school or school board and was being used for school purposes as of July 9, 1987, that being the effective date of P.L. 1987, c. 101 (N.J.S.A. 2C:35-7).
Pursuant to the provisions of P.L. 1988, c. 44, a prosecutor is not precluded from introducing or relying upon any other evidence or testimony to establish a violation of the offense defined in that statute, including use of a map or diagram other than the one approved and adopted pursuant to § 195-1 of this article. The failure of the map approved herein to depict the location and boundaries of any property which is, in fact, used for school purposes and which is owned by or leased to any elementary or secondary school or school board, whether the absence of such depiction is the result of inadvertent omission or the result of any changes in the location and boundaries of such property which have not yet been incorporated into a revised approved map, shall not be deemed to be an official finding and record that such property is not owned by or leased to a school or school board, or that such property is not used for school purposes.
In accordance with and pursuant to the authority of P.L. 1997, c. 327 (N.J.S.A. 2C:35-7.1), a Drug-Free Public Area Map has been drafted by the Borough Engineer, and is hereby approved by the Borough Police Department and it is hereby further approved and adopted as an official finding and record of the location and areas within the Borough of Alpha of property which is utilized as public housing facilities, public parks and public buildings which are owned, leased or controlled by the Borough of Alpha, and of the areas on or within 500 feet of said properties.
The Drug-Free Public Areas Map approved and adopted pursuant to § 195-6 of this article shall continue to constitute an official finding and record of the location and boundaries of areas on or within 500 feet of the real estate comprising public housing facilities, public parks and public buildings which are owned, leased or controlled by the Borough of Alpha, until such time, if any, that this article shall be amended to reflect any additions or deletions with respect to the location and boundaries of the public housing facilities, public parks and/or public buildings and drug-free public areas within the Borough of Alpha.
The Clerk of the Borough of Alpha is hereby directed to receive and to keep on file the original of the map approved and adopted pursuant § 195-6 of this article and to provide, at reasonable cost, a true copy thereof to any person, agency or court which may from time to time request such a copy, along with a certification that such copy is a true copy of the map approved and adopted herein and kept on file. It is hereby further directed that a true copy of such map and of this article shall be provided without cost to the Warren County Clerk and the office of the Warren County Prosecutor.
The location of public housing facilities, public parks and public buildings which are owned, leased or controlled by the Borough of Alpha.
The boundaries of the real property which is utilized in connection with public housing facilities, public parks and public buildings which are owned, leased or controlled by the Borough of Alpha.
That such property continues to be used as public housing facilities, public parks and/or public buildings.
The location and boundaries of areas which are on or within 500 feet of such public housing facilities, public parks and public buildings.
Except as is otherwise expressly noted on the face of the approved and adopted map, all of the property depicted on the map approved and adopted herein as drug-free public areas was owned, leased or controlled by the Borough of Alpha and was being used for public housing facilities, public parks and/or public buildings as of January 9, 1998, that being the effective date of P.L. 1997, c. 327 (N.J.S.A. 2C:35-7.1).
Pursuant to the provisions of P.L. 1997, c. 327 (N.J.S.A. 2C:35-7.1), a prosecutor is not precluded from introducing or relying upon any other evidence or testimony to establish a violation of the offense defined in that statute, including use of a map or diagram other than the one approved and adopted pursuant to § 195-6 of this article. The failure of the map approved herein to depict the location and boundaries of any property which is, in fact, used for public housing facilities, public parks and/or public buildings and which is owned, leased or controlled by the Borough of Alpha, whether the absence of such depiction is the result of inadvertent omission or the result of any change in the location and boundaries of such property which has not yet been incorporated into a revised approved map, shall not be deemed to be an official finding and record that such property is not owned or leased by the Borough of Alpha, or that such property is not used for public housing facilities, public parks or public buildings.
All of the requirements of P.L. 1997, c. 327 (N.J.S.A. 2C:35-7.1) concerning the preparation, approval and adoption of a drug-free public area map have been complied with.